Vineet Laboratories Limited

Vineet Laboratories Limited

Vineet Laboratories Limited has clarified a typographical error in their audited financial results for the quarter and year ended March 31, 2026, stating that the Board of Directors approved the results on August 25, 2026, not May 30, 2026. The company has also disclosed details of outstanding qualified borrowings and incremental qualified borrowings for the financial year ended March 31, 2025.

Vineet Laboratories Limited

Vineet Laboratories Limited has submitted its audited standalone financial results for the fourth quarter and financial year ended March 31, 2026, with an unmodified opinion from its statutory auditors NSVR & Associates LLP.

Vineet Laboratories Limited

Vineet Laboratories Limited has submitted its financial results for the period ended Jun 30, 2026. The Board of Directors has approved the Audited Standalone Financial Results for the fourth quarter and the financial year ended on 31 March, 2026, along with the Audit Report. The company has also made a declaration in respect of the audit report with an unmodified opinion.

Vineet Laboratories Limited

Crisil Ratings Limited has issued a Monitoring Agency Report for Vineet Laboratories Limited, stating that there are no deviations from the objects of the Rights Issue for the quarter ended June 30, 2026.

Vineet Laboratories Limited

Vineet Laboratories Limited has submitted a quarterly compliance report on corporate governance, citing non-applicability of corporate governance provisions under Regulation 15(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, due to paid-up equity share capital and net worth being below the threshold limits.

Vineet Laboratories Limited

Vineet Laboratories Limited has submitted a certificate under SEBI (Depositories and Participants) Regulations, 2018, stating that no securities were received for dematerialization or rematerialization during the first quarter ended June 30, 2026.

Vineet Laboratories Limited

Vineet Laboratories Limited has informed the Exchange regarding Cessation of Mr. Gaddam Venkata Ramana as Managing Director of the company w.e.f. July 21, 2026.

Vineet Laboratories Limited

Vineet Laboratories Limited has informed the Exchange regarding Change in Director(s) of the company. Mr. Rajesh Kumar Kathulla has been appointed as an Additional Director (Executive Category) with effect from 11th day of June, 2026, subject to the approval of the Members of the Company.

Vineet Laboratories Limited

Vineet Laboratories Limited has deferred its Board Meeting scheduled for July 15, 2026, due to unavoidable circumstances. A fresh notice will be intimated to the Exchanges in due course.

Vineet Laboratories Limited

Vineet Laboratories Limited has informed the Exchange about a Board Meeting scheduled on July 15, 2026, to consider and approve the Audited Standalone Financial Results for the Fourth Quarter and Financial Year ended on March 31, 2026.

Vineet Laboratories Limited

Vineet Laboratories Limited has submitted a disclosure under SEBI Takeover Regulations, as per Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.